Art

J-GLOBAL ID：201602216517887845   Reference number：16A1345976

Possible preventive effect of salazosulfapyridine against development of Pneumocystis pneumonia in methotrexate-receiving patients with rheumatoid arthritis

メトトレキセート投与中の関節リウマチ患者における,ニューモシスティス肺炎発症に対するサラゾスルファピリジンの予防効果

Author (12)： MIZUSHINA Kennosuke (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  HIRATA Ayako (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  HAYASHI Norihide (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  TAKENAKA Sayaka (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  ITO Hideki (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  OGURA Takehisa (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  FUJISAWA Yuki (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  IMAMURA Munetsugu (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  YAMASHITA Naoko (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  KUJIME Rie (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  NAKAHASHI Sumie (Toho Univ. Ohashi Medical Center, Tokyo, JPN) ,  KAMEDA Hideto (Toho Univ. Ohashi Medical Center, Tokyo, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 26  Issue： 6  Page： 976-978  Publication year： Nov. 2016 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 短報  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *Pneumocystis carinii pneumonia ,...
Semi thesaurus term： *Pneumonia, Pneumocystis

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1345976&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (2)： Clinical application of antifungal drugs  (GW17070V) ,  Infectious diseases,parasitics diseases in general.  (GD01010H)

Substance index (2)： Salazosulfapyridine ,  Methotrexate

Reference (11)：

• Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M, et al. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Intern Med. 2008;47:915-23.
• Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka Het al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:189-94.
• Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol. 2009;36:898-906.
• Atsumi T, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, et al. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Ann Rheum Dis. [Epub ahead of print]. doi:10.1136/annrheumdis-2015-207511.
• Harigai M, Koike R, Miyasaka N; Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med. 2007;357:1874-6.

Terms in the title (8)： メトトレキセート ,  投与 ,  関節リウマチ ,  患者 ,  ニューモシスティス肺炎 ,  発症 ,  サラゾスルファピリジン ,  予防効果